白细胞介素-36在健康与疾病状态中的作用
本文综述IL-36细胞因子家族的生物学功能及其在多种炎症性疾病中的作用。IL-36有四种亚型,三种激动剂和一种拮抗剂,结合IL-36受体后激活下游信号通路,平衡失调可导致全身炎症反应。IL-36在泛发性脓疱型银屑病(GPP)发病中起核心作用,阻断IL-36信号可改善临床结局,并涉及多种皮肤、肺、肠、肾及感染性疾病和癌症。
要点
- IL-36家族包括三种激动剂(IL-36α/β/γ)和一种拮抗剂(IL-36Ra),均结合IL-36R。
- IL-36激动剂结合IL-36R后招募IL-1RAcP,激活NF-κB和MAPK信号通路。
- IL-36Ra竞争性结合IL-36R抑制IL-1RAcP招募,阻断下游信号。
核心结论
- IL-36在先天性和适应性免疫应答中起关键作用,其家族平衡失调可导致失控的炎症反应。
- IL-36是泛发性脓疱型银屑病(GPP)发病的核心,阻断IL-36介导的信号可改善临床结局。
- IL-36通路异常激活涉及多种皮肤、肺、肠、肾、感染性疾病及癌症。
研究设计与样本
- 本文为综述,总结IL-36通路生物学功能及相关疾病证据。
主要发现
- IL-36α/β/γ结合IL-36R后招募IL-1RAcP,激活NF-κB和MAPK通路;IL-36Ra结合IL-36R抑制IL-1RAcP招募。
- IL-36家族平衡变化可导致全身失控炎症反应。
- IL-36通路异常激活见于斑块状银屑病、脓疱型银屑病、化脓性汗腺炎、痤疮、Netherton综合征、特应性皮炎、坏疽性脓皮病等皮肤疾病。
- IL-36通路异常激活也见于肺(特发性肺纤维化)、肠(肠纤维化、炎症性肠病、Hirschsprung病)、肾(肾小管间质病变)疾病及多种病原体感染(如COVID-19、结核分枝杆菌、铜绿假单胞菌、肺炎链球菌)和癌症。
临床怎么用
- 靶向IL-36信号通路可能用于治疗IL-36介导的炎症性疾病,如GPP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The interleukin (IL)-1 superfamily upregulates immune responses and maintains homeostasis between the innate and adaptive immune systems. Within the IL-1 superfamily, IL-36 plays a pivotal role in both innate and adaptive immune responses. Of the four IL-36 isoforms, three have agonist activity (IL-36α, IL-36β, IL-36γ) and the fourth has antagonist activity (IL-36 receptor antagonist [IL-36Ra]). All IL-36 isoforms bind to the IL-36 receptor (IL-36R). Binding of IL-36α/β/γ to the IL-36R recruits the IL-1 receptor accessory protein (IL-1RAcP) and activates downstream signalling pathways mediated by nuclear transcription factor kappa B and mitogen-activated protein kinase signalling pathways. Antagonist binding of IL-36Ra to IL-36R inhibits recruitment of IL-1RAcP, blocking downstream signalling pathways. Changes in the balance within the IL-36 cytokine family can lead to uncontrolled inflammatory responses throughout the body. As such, IL-36 has been implicated in numerous inflammatory diseases, notably a type of pustular psoriasis called generalized pustular psoriasis (GPP), a chronic, rare, potentially life-threatening, multisystemic skin disease characterised by recurrent fever and extensive sterile pustules. In GPP, IL-36 is central to disease pathogenesis, and the prevention of IL-36-mediated signalling can improve clinical outcomes. In this review, we summarize the literature describing the biological functions of the IL-36 pathway. We also consider the evidence for uncontrolled activation of the IL-36 pathway in a wide range of skin (e.g., plaque psoriasis, pustular psoriasis, hidradenitis suppurativa, acne, Netherton syndrome, atopic dermatitis and pyoderma gangrenosum), lung (e.g., idiopathic pulmonary fibrosis), gut (e.g., intestinal fibrosis, inflammatory bowel disease and Hirschsprung's disease), kidney (e.g., renal tubulointerstitial lesions) and infectious diseases caused by a variety of pathogens (e.g., COVID-19; Mycobacterium tuberculosis, Pseudomonas aeruginosa, Streptococcus pneumoniae infections), as well as in cancer. We also consider how targeting the IL-36 signalling pathway could be used in treating inflammatory disease states.
引用
- Sugiura K, Fujita H, Komine M, et al. The role of interleukin-36 in health and disease states. J Eur Acad Dermatol Venereol. 2024. PMID: 38779986. doi:10.1111/jdv.19935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。